ARTICLE | Company News
Galderma sales and marketing update
October 7, 2013 7:00 AM UTC
Galderma launched Mirvaso brimonidine tartrate 0.33% in pharmacies in the U.S. to treat facial erythema of rosacea in adult patients. A 30 g tube of the product, which was approved by FDA in August, ...